Clinical Trial

Endoscopic Treatment for Zenker's Diverticulum

Recruiting
View on ClinicalTrials.gov →
Summary
Zenker's diverticulum (ZD) is a rare benign condition, due to an acquired sac-like outpouching of the mucosa and submucosa layers originating from the pharyngoesophageal junction. Endoscopic techniques like flexible endoscopic septum division (FESD) or per-oral endoscopic septotomy (POES), represent a minimally invasive alternative to surgery or to rigid endoscopic procedure to treat ZD. The goal of the research will be to evaluate the safety of the procedures and to measure Zenker-symptom severity in all patients treated by endoscopic procedures.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-05-09; most recent amendment 2022-09-19.
Trial Details
NCT Number NCT03948438
Lead Sponsor Istituto Clinico Humanitas
Conditions Zenker Diverticulum
Enrollment 400 participants
Start Date 2009-01-01
Primary Completion 2028-12-30 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2022-09-21